Table 3.
(i) To avoid glitazones | |
(ii) Good glycaemic control | |
(iii) Minimizing of hypoglycemic episodes | |
(iv) Prevention of diabetic complications, especially kidney disease | |
(v) To assess and prevent falls | |
(vi) Supplementation with calcium and vitamin D | |
(vii) Specific antiporotic medication (antiresorptive or osteoanabolic treatment) |